Company intelligence / Profile preview

Medtronic BioPharma

Ownership: Private
Employees: ~95000
Development stage: Other

Overview

Medtronic is a global leader in medical technology, services, and solutions. While primarily known as a medical device giant, the company operates a significant BioPharma and biologics business focused on drug-device combination products. Key offerings include the Infuse Bone Graft, which utilizes recombinant human bone morphogenetic protein-2, and advanced drug-delivery systems for chronic pain and diabetes management. Medtronic's BioPharma initiatives integrate therapeutic agents with sophisticated hardware to improve clinical outcomes across cardiovascular, neuroscience, and surgical portfolios.

Therapeutic areas: EndocrinologyNeurologyCardiovascular
Modalities: DeviceBiologicSmall moleculeDrug-device combination
Industry: Pharma

Partnerships

Cosmo PharmaceuticalsNVIDIACathay Health

Beyond the preview

Go deeper on Medtronic BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medtronic BioPharma.